Obesity Clinical Trial
Official title:
The Effect of Breakfast Test Products on Acute Satiety Scores in Different Test Conditions
Rationale: The worldwide prevalence of obesity increases rapidly, and at the moment there
are more overweight than underweight people in the world. This is partly caused by increased
energy, or food intake. One of the physiological factors regulating the food intake pattern
is satiety. Though the regulation of food intake has been studied quite extensively, the
underlying mechanisms are not well elucidated yet and still new factors involved in this
regulation are being found. Therefore, in this study the investigators aim to develop an in
vitro screening tool combined with an in silico model for prediction of satiety, for cost-
and time - effective screening of satiating properties of new and existing complex food
products and (functional) ingredients, based on actual satiety scores measured. A second aim
of the Wholegrain Satiety project is to evaluate satiating properties of different types of
wholegrain breads and other oat based products, both for validation purposes and to
strengthen the scientific evidence for health benefits of wholegrain products. As part of
this study, acute satiety scores after consumption of various breakfast products in
well-controlled clinical conditions will be compared with satiety scores obtained in 'at
home' test conditions.
Objective: The current study aims to compare the acute satiety effect of carbohydrate
breakfast products.
| Status | Completed |
| Enrollment | 32 |
| Est. completion date | July 2016 |
| Est. primary completion date | December 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 18 Years to 50 Years |
| Eligibility |
Inclusion Criteria: 1. Female subjects aged 18-50 years; 2. BMI: 22-32 kg/m2; 3. Written consent regarding participation after full information regarding all details of the study; 4. Normal Dutch eating habits (consuming mostly three main meals per day; used to eat bread for lunch; used to consume dietary fibres; like the test products (P9619 F02)); 5. Normal dietary eating behaviour (non-restrained eaters, estimated with the Dutch Eating Behaviour Questionnaire; P9619 F06); 6. Healthy as assessed by the Health and Lifestyle questionnaire (P9619 F02); 7. Subjects with a normal dietary fibre intake (between 10-30 grams/day) (P9619 F07); 8. Voluntary participation; 9. Willing to comply with study procedures; 10. Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data by TNO; 11. Have a laptop with adequate internet access at home and experience how to use it, and willing to use and bring it to TNO. Exclusion Criteria: 1. On-going or recent treatment for diabetes, hypertension, coronary heart disease, psychiatric conditions, inflammatory chronic disease - rheumatoid arthritis, Crohn Disease, ulcerous colitis, chronic constipation, eating disorders; 2. Reported postmenopausal; 3. Having menstruation problems, e.g. PCOS; 4. Reported to be on a slimming diet or other dietary treatment (currently or during last two months, like vegetarian diet, lactose restricted diet etc.); 5. On-going use of any slimming preparations; 6. Any kind of dysfunction of digestive tract, food allergies/intolerances related to the supplied test products (like gluten intolerance), chronic constipation, recent/actual gastroenteritis; 7. Reported unexplained weight loss or gain of > 2 kg in the three months prior to the pre-study screening 8. Smoking; 9. Subjects with a high level of physical activity (> 5h intense sporting activity/week); 10. Heavy alcohol consumers, no more than 14 units per week (1 unit represents 1 standard glass/portion of alcohol, independent of the type of alcoholic drink); 11. Physical, mental or practical limitations in using computerized systems; 12. Partner or first or second-degree relative from TNO personnel stationed at TNO Zeist. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | TNO Quality of Life | Zeist | Utrecht |
| Lead Sponsor | Collaborator |
|---|---|
| TNO | Nederlands Bakkerij Centrum, PepsiCo, Inc. |
Netherlands,
Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, Mela D, Salah S, Schuring E, van der Knaap H, Westerterp M. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010 Mar;11(3):251-70. doi: 10.1111/j.1467-789X.2010.00714.x. Epub 2010 Jan 29. Review. — View Citation
Marschollek M, Gietzelt M, Schulze M, Kohlmann M, Song B, Wolf KH. Wearable sensors in healthcare and sensor-enhanced health information systems: all our tomorrows? Healthc Inform Res. 2012 Jun;18(2):97-104. doi: 10.4258/hir.2012.18.2.97. Epub 2012 Jun 30 — View Citation
Pasman WJ, Blokdijk VM, Bertina FM, Hopman WP, Hendriks HF. Effect of two breakfasts, different in carbohydrate composition, on hunger and satiety and mood in healthy men. Int J Obes Relat Metab Disord. 2003 Jun;27(6):663-8. — View Citation
Raben A, Tagliabue A, Astrup A. The reproducibility of subjective appetite scores. Br J Nutr. 1995 Apr;73(4):517-30. Erratum in: Br J Nutr 1995 Aug;74(2):283. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Hunger and satiety feelings for different compositions of breakfasts | Response in hunger and satiety feelings due to breakfast consumption over time (four hours) will be measured with a visual analogue rating scale varying of no hunger (0 mm) to very hungry (100 mm) | four hours | No |
| Secondary | Level of control of the conduct (controlled at TNO versus less control at home) | The differences in hunger and satiety scores measured with visual analogue rating scales will be monitored for four hours after breakfast consumption at TNO (controlled setting) versus at home (less control) | Four hour follow-up on hunger and satiety feelings after each breakfast session | No |
| Secondary | Blood glucose | In the controlled condition at TNO the blood glucose response will be monitored with finger pricks and direct blood glucose measurement. | two hours | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |